doi: 10.3389/fsurg.2025.1618362 Received 25 April 2025 Accepted 28 August 2025 Published 15 September 2025 Volume 12 - 2025 Edited by Rafael De La Garza Ramos, Albert Einstein College of Medicine, United States Reviewed by Marica Eoli, IRCCS Carlo Besta Neurological Institute Foundation, Italy Hajnalka Rajnai, Semmelweis University, Hungary Zhenhua Li, Brigham and Women's Hospital and Harvard Medical School, United States Updates Copyright 2025 Guranda, Wach, Gresir, Braune, Kuzman and Nestler
Next is a medical consultation with the doctor to review your results and understand your goals, lifestyle and wellness priorities
This study aimed to clarify the association between GLP-1 RA use and GI cancer risk
approvals, so Canadians living with type 2 diabetes may be waiting a little longer
Patients in the United States are filing lawsuits to hold Novo Nordisk accountable for not telling them about the full range of risks of Ozempic
The GLP-1 brochure also includes a QR code that takes customers to a product page featuring protein and fiber options